one step ahead - Writing the next chapter of growth
We are excited to welcome you to our Capital Markets Day 2026. This year’s Capital Markets Day focuses on the next chapter of growth for Basilea and how we are continuing to advance our antifungal and antibacterial business. Members of our executive management team will guide you through our strategic direction, "Agenda 2030", recent developments and commercial priorities.
Expert Perspectives on Infectious Diseases
In addition, two internationally renowned experts in infectious diseases will share their perspective and insights: Dr. Oliver Cornely (Professor of Translational Research and Clinical Trials in Fungal Infection at the University of Cologne) and Dr. David Paterson (Professor of Medicine at the National University of Singapore). The event concludes with a networking reception.
KOL Sessions by
Oliver Cornely
Professor of Translational Research at the Faculty of Medicine, University of Cologne
David Paterson
Professor of Medicine at the National University of Singapore, with a focus on antimicrobial resistance (AMR) and international clinical trial networks